Clinical trial
The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment
NCT01667406 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment
- Lead sponsor
- Imperial College London
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 1, 2012
- Completion date
- October 11, 2016
- Enrollment
- 175 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.